Meng Yao Chen

Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan.